Financial statements Centrum Mikrobiologii Klinicznej
Balance sheet data of CENTRUM MIKROBIOLOGII KLINICZNEJ
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
|---|---|---|---|---|---|---|---|
| Total assets | 1 256 240,75 | 1 228 724,25 | 1 195 019,00 | 1 150 051,16 | 1 202 448,01 | 1 149 004,15 | 905 777,99 |
| A. Fixed assets | 4 775,86 | 955,42 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 1 251 464,89 | 1 227 768,83 | 1 195 019,00 | 1 150 051,16 | 1 202 448,01 | 1 149 004,15 | 905 777,99 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 256 240,75 | 1 228 724,25 | 1 195 019,00 | 1 150 051,16 | 1 202 448,01 | 1 149 004,15 | -307 201,31 |
| A. Equity | 1 209 202,05 | 1 180 018,43 | 1 184 952,23 | 1 111 770,55 | 1 127 997,18 | 1 092 841,89 | -410 507,61 |
| B. Liabilities and provisions for liabilities | 47 038,70 | 48 705,82 | 10 066,77 | 38 280,61 | 74 450,83 | 56 162,26 | 103 306,30 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 47 038,70 | 48 705,82 | 10 066,77 | 38 280,61 | 74 450,83 | 56 162,26 | 103 306,30 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.